Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
The establishment of Nanoform USA follows the recent appointment of Sally Langa as Head of US Sales. Langa brings 30 years of valuable commercial experience in Pharma, having held senior positions at Catalent Pharma, Patheon and Halo Pharmaceutical. The expansion also coincides with increasing interest in Nanoform's technology within the US marketplace and the company's application for GMP status at its Finnish site, which is expected to further fuel demand for Nanoform's proprietary CESS® technology.
"We are tremendously excited to have officially established our presence in the US with a wholly owned subsidiary. This comes as a natural next step for our company as we continue to expand the reach of our nanonization™ technology," Prof. Edward Haeggstrom, Nanoform CEO, said.
"I am thrilled we are establishing Nanoform USA Inc. With this strategic expansion, we now have a strong foundation on which to continue to grow our presence in the US," Miguel Calado, Vice Chairman of the Nanoform Board, said.